Logo image of MLSS

MILESTONE SCIENTIFIC INC (MLSS) Stock Fundamental Analysis

USA - NYSE Arca - NYSEARCA:MLSS - US59935P2092 - Common Stock

0.354 USD
+0.01 (+1.43%)
Last: 12/5/2025, 8:04:00 PM
0.36 USD
+0.01 (+1.69%)
After Hours: 12/5/2025, 8:04:00 PM
Fundamental Rating

2

Taking everything into account, MLSS scores 2 out of 10 in our fundamental rating. MLSS was compared to 187 industry peers in the Health Care Equipment & Supplies industry. MLSS may be in some trouble as it scores bad on both profitability and health. MLSS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MLSS has reported negative net income.
MLSS had a negative operating cash flow in the past year.
MLSS had negative earnings in each of the past 5 years.
MLSS had a negative operating cash flow in each of the past 5 years.
MLSS Yearly Net Income VS EBIT VS OCF VS FCFMLSS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

Looking at the Return On Assets, with a value of -86.63%, MLSS is doing worse than 76.72% of the companies in the same industry.
MLSS has a worse Return On Equity (-208.80%) than 73.55% of its industry peers.
Industry RankSector Rank
ROA -86.63%
ROE -208.8%
ROIC N/A
ROA(3y)-57.54%
ROA(5y)-48.91%
ROE(3y)-84.14%
ROE(5y)-67.88%
ROIC(3y)N/A
ROIC(5y)N/A
MLSS Yearly ROA, ROE, ROICMLSS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

Looking at the Gross Margin, with a value of 72.80%, MLSS belongs to the top of the industry, outperforming 82.01% of the companies in the same industry.
MLSS's Gross Margin has improved in the last couple of years.
MLSS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 72.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.77%
GM growth 5Y1.76%
MLSS Yearly Profit, Operating, Gross MarginsMLSS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

2

2. Health

2.1 Basic Checks

MLSS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MLSS has been increased compared to 1 year ago.
MLSS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, MLSS has a worse debt to assets ratio.
MLSS Yearly Shares OutstandingMLSS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MLSS Yearly Total Debt VS Total AssetsMLSS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -20.49, we must say that MLSS is in the distress zone and has some risk of bankruptcy.
MLSS has a worse Altman-Z score (-20.49) than 89.42% of its industry peers.
MLSS has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
MLSS has a Debt to Equity ratio (0.25) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z -20.49
ROIC/WACCN/A
WACC8.77%
MLSS Yearly LT Debt VS Equity VS FCFMLSS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 2.03 indicates that MLSS has no problem at all paying its short term obligations.
MLSS has a worse Current ratio (2.03) than 62.43% of its industry peers.
A Quick Ratio of 0.69 indicates that MLSS may have some problems paying its short term obligations.
With a Quick ratio value of 0.69, MLSS is not doing good in the industry: 87.30% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 0.69
MLSS Yearly Current Assets VS Current LiabilitesMLSS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 37.92% over the past year.
MLSS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.19%.
Measured over the past years, MLSS shows a small growth in Revenue. The Revenue has been growing by 0.61% on average per year.
EPS 1Y (TTM)37.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)-12.19%
Revenue growth 3Y-5.73%
Revenue growth 5Y0.61%
Sales Q2Q%-6.11%

3.2 Future

The Earnings Per Share is expected to grow by 9.70% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.17% on average over the next years.
EPS Next Y26.33%
EPS Next 2Y22.07%
EPS Next 3Y9.7%
EPS Next 5YN/A
Revenue Next Year-0.48%
Revenue Next 2Y3.44%
Revenue Next 3Y4.17%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MLSS Yearly Revenue VS EstimatesMLSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
MLSS Yearly EPS VS EstimatesMLSS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -0.05 -0.1 -0.15 -0.2 -0.25

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MLSS. In the last year negative earnings were reported.
Also next year MLSS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MLSS Price Earnings VS Forward Price EarningsMLSS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MLSS Per share dataMLSS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.07%
EPS Next 3Y9.7%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MLSS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MILESTONE SCIENTIFIC INC

NYSEARCA:MLSS (12/5/2025, 8:04:00 PM)

After market: 0.36 +0.01 (+1.69%)

0.354

+0.01 (+1.43%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13 2025-11-13/amc
Earnings (Next)04-13 2026-04-13/bmo
Inst Owners5.67%
Inst Owner Change-1.6%
Ins Owners2.94%
Ins Owner Change-1.58%
Market Cap27.84M
Revenue(TTM)8.63M
Net Income(TTM)-6.97M
Analysts82.5
Price Target1.02 (188.14%)
Short Float %3.69%
Short Ratio1.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-63.4%
Min EPS beat(2)-96.08%
Max EPS beat(2)-30.72%
EPS beat(4)0
Avg EPS beat(4)-104.25%
Min EPS beat(4)-194.12%
Max EPS beat(4)-30.72%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-11.25%
Min Revenue beat(2)-12.41%
Max Revenue beat(2)-10.09%
Revenue beat(4)0
Avg Revenue beat(4)-13.44%
Min Revenue beat(4)-25.64%
Max Revenue beat(4)-5.64%
Revenue beat(8)0
Avg Revenue beat(8)-18.46%
Revenue beat(12)3
Avg Revenue beat(12)-10.19%
Revenue beat(16)5
Avg Revenue beat(16)-9.84%
PT rev (1m)-50%
PT rev (3m)-38.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)7.14%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-6.13%
Revenue NY rev (3m)-7.08%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.06
P/FCF N/A
P/OCF N/A
P/B 8.33
P/tB 8.63
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.12
BVpS0.04
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -86.63%
ROE -208.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 72.8%
FCFM N/A
ROA(3y)-57.54%
ROA(5y)-48.91%
ROE(3y)-84.14%
ROE(5y)-67.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.77%
GM growth 5Y1.76%
F-Score3
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16.55%
Cap/Sales 0.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.03
Quick Ratio 0.69
Altman-Z -20.49
F-Score3
WACC8.77%
ROIC/WACCN/A
Cap/Depr(3y)17.16%
Cap/Depr(5y)20.45%
Cap/Sales(3y)0.09%
Cap/Sales(5y)0.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y26.33%
EPS Next 2Y22.07%
EPS Next 3Y9.7%
EPS Next 5YN/A
Revenue 1Y (TTM)-12.19%
Revenue growth 3Y-5.73%
Revenue growth 5Y0.61%
Sales Q2Q%-6.11%
Revenue Next Year-0.48%
Revenue Next 2Y3.44%
Revenue Next 3Y4.17%
Revenue Next 5YN/A
EBIT growth 1Y-3.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.04%
OCF growth 3YN/A
OCF growth 5YN/A

MILESTONE SCIENTIFIC INC / MLSS FAQ

Can you provide the ChartMill fundamental rating for MILESTONE SCIENTIFIC INC?

ChartMill assigns a fundamental rating of 2 / 10 to MLSS.


What is the valuation status for MLSS stock?

ChartMill assigns a valuation rating of 0 / 10 to MILESTONE SCIENTIFIC INC (MLSS). This can be considered as Overvalued.


What is the profitability of MLSS stock?

MILESTONE SCIENTIFIC INC (MLSS) has a profitability rating of 1 / 10.